← Return to Evenity

Discussion

Evenity

Osteoporosis & Bone Health | Last Active: 5 hours ago | Replies (46)

Comment receiving replies
@mayblin

The graph👇is from evenity phase 3 clinical trial. It is dual-action based on bone turnover markers with a net anabolic effect obvious in early stages, although bmd kept increasing in later half of the year-long treatment. However the interpretation is up to everyone. The advantages or disadvantages of the hypothesized “modeling based” bone building by evenity, i.e., building new bones at quiescent bone surface, is yet to be studied scientifically.

Jump to this post


Replies to "The graph👇is from evenity phase 3 clinical trial. It is dual-action based on bone turnover markers..."

Try to reload the graph: